Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Apr;30(2):145-64.
doi: 10.1007/s00281-008-0109-4. Epub 2008 Mar 5.

Advances in the Diagnosis and Immunotherapy for Ocular Inflammatory Disease

Affiliations
Review

Advances in the Diagnosis and Immunotherapy for Ocular Inflammatory Disease

Steven Yeh et al. Semin Immunopathol. .

Abstract

Significant advances in the diagnosis and therapy for uveitis have been made to improve the quality of care for patients with ocular inflammatory diseases. While traditional ophthalmic examination techniques, fluorescein angiography, and optical coherence tomography continue to play a major role in the evaluation of patients with uveitis, the advent of spectral domain optical coherence tomography and fundus autofluorescence into clinical practice provides additional information about disease processes. Polymerase chain reaction and cytokine diagnostics have also continued to play a greater role in the evaluation of patients with inflammatory diseases. The biologic agents, a group of medications that targets cytokines and other soluble mediators of inflammation, have demonstrated promise in targeted immunotherapy for specific uveitic entities. Their ophthalmic indications have continued to expand, improving the therapeutic armentarium of uveitis specialists.

Similar articles

See all similar articles

Cited by 8 articles

See all "Cited by" articles

References

    1. Ophthalmic Res. 2005 Mar-Apr;37(2):112-6 - PubMed
    1. J Clin Virol. 2004 Mar;29(3):206-9 - PubMed
    1. Am J Ophthalmol. 2000 Oct;130(4):492-513 - PubMed
    1. Ophthalmology. 1991 Jun;98(6):944-51; discussion 951-2 - PubMed
    1. Dermatology. 2006;213(3):204-14 - PubMed

LinkOut - more resources

Feedback